The QualityStocks Daily Wednesday, March 13th, 2024

Today's Top 3 Investment Newsletters

MarketClub Analysis(LSF) $1.9000 +104.30%

QualityStocks(TCON) $0.6310 +61.79%

Schaeffer's(GXAI) $8.0400 +51.13%

The QualityStocks Daily Stock List

Tracon Pharmaceuticals (TCON)

reported earlier on Tracon Pharmaceuticals (TCON), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Tracon Pharmaceuticals Inc. (NASDAQ: TCON) is a biopharmaceutical firm that is engaged in developing and commercializing therapies for cancer.

The firm has its headquarters in San Diego, California and was incorporated in October 2004. Prior to its name change in March 2005, the firm was known as Lexington Pharmaceuticals Inc. It operates as part of the scientific research and development services industry, under the healthcare sector. The firm has two companies in its corporate family and serves consumers in the United States.

The company is party to license and collaboration agreements with Case Western Reserve University to develop TRC102; I-Mab Biopharma, to develop CD73 antibody TJ004309; Jiangsu Alphamab Biopharmaceuticals Co. Ltd to develop envafolimab; and 3D Medicines Co. Ltd. It is also party to a development agreement with the National Cancer Institute.

The enterprise’s clinical-stage products include a CD73 antibody dubbed TJ004309, which is in phase I clinical development and has been developed to treat solid tumors; a small molecule known as TRC102, which is undergoing phase1 clinical trials for the treatment of glioblastoma, lung cancer, lymphomas and solid tumors and phase 2 clinical trials evaluating its effectiveness in treating mesothelioma. It is also developing YH001 for the treatment of a range of cancer indications and envafolimab, to treat soft tissue sarcoma.

The firm recently announced its latest financial results and remains focused on advancing its product candidates. The success and approval of these formulations will not only benefit patients with certain indications but also bring in additional revenues as well as investors into the firm, which will be good for its growth.

Tracon Pharmaceuticals (TCON), closed Wednesday's trading session at $0.631, up 61.7949%, on 26,673,739 volume. The average volume for the last 3 months is 12.89M and the stock's 52-week low/high is $0.1255/$2.19.

Kintara Therapeutics (KTRA)

reported earlier on Kintara Therapeutics (KTRA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Kintara Therapeutics, Inc. (NASDAQ: KTRA) (OTC: DMPWW) (FRA: 3DM) is a clinical stage drug development firm that is engaged in the development and commercialization of anti-cancer therapies for the treatment of cancer.

The firm has its headquarters in San Diego, California and was incorporated in 2009, on June 24th by William J. Garner, Dennis M. Brown and Jeffrey A. Bacha. Prior to its name change in August 2020, the firm was known as DelMar Pharmaceuticals Inc. It operates as part of the scientific research and development services industry and serves consumers around the globe. The firm has two companies in its corporate family.

The company is focused on identifying commercial and clinical-stage compounds and establishing a scientific rationale for developing orphan drug indications. It has teamed up with outstanding clinical research and academic institutions across the globe to support the development of its cancer treatments. It is party to a strategic collaboration with Guangxi Wuzhou Pharmaceutical Co. Ltd, which entails manufacturing and selling VAL-083 in China.

The enterprise’s product pipeline comprises of two late-stage therapeutics, including a photodynamic therapy dubbed REM-001 for the treatment of cutaneous metastatic breast cancer; and a DNA-targeting agent dubbed VAL-083 for the treatment of drug-resistant solid tumors like diffuse intrinsic pontine glioma, non-small cell lung cancer, ovarian cancer and glioblastoma multiforme.

The company recently announced its financial results for its fiscal year ended June 2021, with its CEO noting that the company was well-positioned both on its corporate and clinical development front, having entered into purchase agreements with investors to raise monies which will be used for the company’s corporate working capital needs and ongoing clinical studies.

Kintara Therapeutics (KTRA), closed Wednesday's trading session at $0.1221, up 46.0526%, on 145,512,020 volume. The average volume for the last 3 months is 8,474 and the stock's 52-week low/high is $0.081/$5.98.

Creatd Inc. (CRTD)

reported earlier on Creatd Inc. (CRTD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Creatd Inc. (NASDAQ: CRTD) is a technology firm that is engaged in the developing digital communities, e-commerce opportunities and marketing branded digital content.

The firm is based in Fort Lee, New Jersey and was incorporated in 1999, on December 30th by Rick Schwartz and Jeremy Phillip Frommer. Before changing its name in September 2020, the firm was known as Jerrick Media Holdings Inc. It generates revenues in the form of affiliate sales, branded content, creator subscriptions and managed services.

The enterprise has 3 platforms, i.e. Recreatd, Creatd Partners and Vocal Ventures. Its primary technology platform Vocal offers creators, podcasters and bloggers, curated and safe communities and storytelling tools, as well as opportunities to monetize their content. It also allows them to partner with brands that want to reach their audiences as well as connect with their ideal audiences.

The company provides an in-house marketing agency for e-commerce and direct-to-consumer clients, which offers performance marketing and management services, called Seller’s Choice. This is in addition to providing Recreatd, which holds legacy media assets and intellectual property, including media memorabilia, photographs and acquired artwork, to reactivate e-commerce properties and archival media assets.

The firm recently released their 2020 financial results, which show that not only did the sales, marketing and business development efforts expand, their net revenue tripled. With tactical position efforts underway to boost revenue projections even higher and new investment partners currently in development, the firm has a lot of good things in store for its stakeholders, it seems.

Creatd Inc. (CRTD), closed Wednesday's trading session at $9.57, up 45%, on 33,904 volume. The average volume for the last 3 months is 99,590 and the stock's 52-week low/high is $0.20/$107.50.

Medicenna Therapeutics Corp. (MDNAF)

reported earlier on Medicenna Therapeutics Corp. (MDNAF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company based in Toronto, Ontario. It focuses on oncology and the development and commercialization of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines™ (ECs) for the treatment of a wide array of cancers. Medicenna Therapeutics lists on the OTC Markets Group’s OTCQB.

Medicenna Therapeutics is developing an innovative set of tunable Superkines™, which can be fused with pro-apoptotic proteins to precisely deliver potent cell-killing agents to cancer cells, the immunosuppressive tumor micro-environment and cancer stem cells without harming healthy cells.

Supported by a US$14.1M non-dilutive grant from CPRIT (Cancer Prevention and Research Institute of Texas), Medicenna Therapeutics’ lead IL4-EC, MDNA55, has completed enrolling patients in a Phase 2b clinical trial for rGBM, the most common and uniformly fatal form of brain cancer, at top-ranked brain cancer centers in the United States. MDNA55 has been studied in five clinical trials involving 132 patients. This includes 112 adults with rGBM.

MDNA55 has demonstrated compelling efficacy. Moreover, it has obtained Fast-Track and Orphan Drug status from the FDA (Food and Drug Administration) and FDA/EMA (European Medicines Agency) respectively. MDNA55 targets Temodar-resistant tumors. Delivery by CED infusion of MDNA55 bypasses the BBB (Blood Brain Barrier). Precision delivery achieves high doses without systemic exposure.

Medicenna also develops MDNA57 for solid tumors and on-malignant cells of the tumor micro-environment; and MDNA109, an IL-2 agonist to treat cancer immunotherapies. The Company also develops MDNA209, an IL-2 antagonist for autoimmune diseases; and MDNA413, a dual IL-4/IL-13 antagonist for the treatment of solid tumors, atopic dermatitis, asthma, and fibrosis. Furthermore, Medicenna develops MDNA132, an IL-13 agonist to treat solid tumors, and IL 13Ralpha2 chimeric antigen receptor T cell.

Medicenna Therapeutics Corp. (MDNAF), closed Wednesday's trading session at $1.13, up 24.1758%, on 278,525 volume. The average volume for the last 3 months is 682,713 and the stock's 52-week low/high is $0.151251/$1.15.

Sonendo Inc. (SONX)

reported earlier on Sonendo Inc. (SONX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sonendo Inc. (NYSE: SONX) is a commercial-stage medical technology firm that is focused on the development, manufacture and commercialization of devices for root canal therapy.

The firm has its headquarters in Laguna Hills, California and was incorporated in 2006. Prior to its name change in March 2011, the firm was known as Dentatek Corp. It operates as part of the medical devices industry, under the healthcare sector. The firm has three companies in its corporate family and serves consumers around the globe, with a focus on Canada and the United States.

The company’s mission is to save teeth and prevent the progression of tooth decay. It does so by enabling superior disinfection and cleaning of the root canal system with a streamlined workflow for practices and minimal post-operative pain for individuals.

The enterprise provides a practice management software known as the Digital Office, which enables an integrated digital office for dental practitioners. It also provides a material used to create a seal platform on top of the tooth crown, dubbed SoundSeal; and a branded EDTA liquid solution which is used to help disinfect the root canal system. In addition to this, the enterprise offers a tooth decay treatment device for disinfecting and cleaning the microscopic spaces between teeth known as GentleWave.

The firm is focused on increasing the adoption of its GentleWave System, which has numerous clinical benefits, especially in comparison to current methods of root canal therapy. This will not only bring in additional revenues but also extend its consumer reach, which will positively influence investments.

Sonendo Inc. (SONX), closed Wednesday's trading session at $0.123465, up 23.5886%, on 1,507,870 volume. The average volume for the last 3 months is 784,626 and the stock's 52-week low/high is $0.045/$2.175.

First Wave BioPharma (FWBI)

reported earlier on First Wave BioPharma (FWBI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

First Wave BioPharma Inc. (NASDAQ: FWBI) (FRA: 3660) is a clinical-stage biopharmaceutical firm that is focused on developing non-systemic targeted therapies for gastrointestinal ailments.

The firm has its headquarters in Boca Raton, Florida and was incorporated in 2014, on January 30th. Prior to its name change in September 2021, the firm was known as AzurRx BioPharma Inc. The firm serves consumers in France and the United States.

The enterprise is advancing a therapeutic development pipeline with various clinical-stage programs which have been built around its pair of proprietary technologies, i.e. a recombinant lipase enzyme designed to allow the digestion of fats and other nutrients, the biologic adrulipase; and an oral small molecule with anti-inflammatory and anti-viral properties known as niclosamide, which allow patients suffering from ulcerative proctitis, gastrointestinal infections and other colitis and diarrhea diseases to receive proper treatment. The enterprise’s niclosamide portfolio is led by 3 clinical programs: FW-ICI-AC for Grade 1 and 2 Immune Checkpoint inhibitor-associated colitis and diarrhea in advanced oncology patients; FW-UP for ulcerative proctosigmoiditis and ulcerative proctitis; and FW-COV for coronavirus gastrointestinal infections. Additional niclosamide formulations entering pipeline development include FW-CD, which has been developed for Crohn’s disease, and FW-UC, indicated for ulcerative colitis. In addition to this, the enterprise is advancing its adrulipase FW-EPI formulation, developed to treat exocrine pancreatic insufficiency in patients with chronic pancreatitis and cystic fibrosis.

The firm, which recently filed a provisional patent application for its adrulipase formulation, is focused on strengthening and expanding its adrulipase intellectual property portfolio through the advancement of its FW-EPI clinical development program.

First Wave BioPharma (FWBI), closed Wednesday's trading session at $6.53, up 14.9648%, on 123,485 volume. The average volume for the last 3 months is 951,911 and the stock's 52-week low/high is $2.75/$75.00.

Cresco Labs, Inc. (CRLBF)

reported earlier on Cresco Labs, Inc. (CRLBF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cresco Labs, Inc. is one of the largest vertically integrated multi-state cannabis operators in the U.S. The Company employs a consumer-packaged goods (CPG) approach to cannabis. The design of its family of brands is to meet the needs of all consumer segments. Its products sell in more than 700 dispensaries across the nation. Cresco has a number of owned dispensaries. Cresco Labs is headquartered in Chicago, Illinois and the Company lists on the OTCQX.

Cresco Labs is a vertically integrated cannabis company. It controls its cultivation, manufacturing, extraction and packaging practices. It is involved at every point in the seed-to-sales process. Its facilities are powered by world-class agronomists, manufacturing experts, and state-of-the-art agricultural equipment.

Cresco packages, ships, and distributes its products nationwide, including locations owned and operated by its team. Cresco has launched the industry’s first national comprehensive Social Equity and Educational Development (SEED) initiative. The design of this is to ensure that all members of society have the skills, knowledge and opportunity to work in and own businesses in the cannabis industry.

Cresco Labs’ brands include some of the most recognized and trusted national brands. These include Cresco, Remedi, and Mindy’s, a line of edibles created by James Beard Award-winning chef Mindy Segal. Sunnyside is Cresco Labs’ national dispensary brand. Sunnyside is a wellness-centered retailer designed to build trust, education, and convenience for existing and new cannabis consumers.

Cresco Labs, Inc. (CRLBF), closed Wednesday's trading session at $1.79, up 14.7436%, on 862,773 volume. The average volume for the last 3 months is 529,410 and the stock's 52-week low/high is $1.00/$2.77.

Liquidmetal Technologies (LQMT)

reported earlier on Liquidmetal Technologies (LQMT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Liquidmetal Technologies Inc. (OTCQB: LQMT) is a materials technology firm that is engaged in designing, developing, manufacturing and selling parts and products from bulk amorphous alloys to consumers in different industries.

The firm has its headquarters in Lake Forest, California and was incorporated in 1987. It operates as part of the metal fabrication industry, under the industrials sector. The firm serves consumers around the globe, with a primary focus on the United States.

The enterprise utilizes a patented injection molding process to manufacture amorphous metal components. These metals are a class of alloys which have been designed to maintain amorphous atomic structures in a solid state. These metals are also referred to as bulk metallic glass and allow precious parts with very low shrinkage to be molded as well as for the achievement of great mechanical properties. The enterprise provides bulk amorphous alloy custom parts and products for various applications, including sports and leisure goods, automotive components, military, medical products and non-consumer electronic devices. It also provides prototype and tooling parts, like demonstration parts and test samples for consumers with products in development; and royalty and product licensing services. The enterprise also partners with third party licensees and manufacturers for the development and commercialization of liquidmetal alloy products.

The company recently entered into a sub-license agreement with Amorphous Technologies Inc. This venture will entail the development of golf clubs using the company’s technology and selling them around the world, starting with Japan, as the sport is very popular there. This move will bring in significant additional revenue into the company and help extend its consumer reach, which will positively impact its growth.

Liquidmetal Technologies (LQMT), closed Wednesday's trading session at $0.06, up 14.2857%, on 3,309,912 volume. The average volume for the last 3 months is 190,010 and the stock's 52-week low/high is $0.031/$0.0885.

TruGolf (TRUG)

reported earlier on TruGolf (TRUG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

TruGolf Holdings Inc. (NASDAQ: TRUG) is an indoor golf gaming solutions firm focused on the sale and distribution of golf simulator software and hardware.

The firm has its headquarters in Centerville, Utah and was incorporated in 1982. It operates as part of the electronic gaming and multimedia industry, under the communication services sector. The firm serves consumers around the globe.

The company has built video games, hardware solutions, and an e-sports platform to connect golfers around the world with E6 Connect. It offers Apogee, a technologically advanced launch monitor, which has a ceiling-mounted, camera-based system that accurately measures club and ball data without the need for specialty balls or marked clubs. Its E6 Interactive Sports Camera is a standalone tracking system that can be added to any existing golf simulator structure and adds sports arcade games. Its golf simulators include TruGolf MAX, professional golf simulators, commercial golf simulators, custom golf simulators and portable golf simulators. Its software includes E6 Apex, E6 Connect, E6 Connect Commercial Suite, and E6 Range. It also offers a TruGolf Mini golf simulator, which includes a gyroscopic sensor that pairs with E6 Connect software and provides data-driven insights after every shot.

The enterprise, which recently concluded its business combination with special purpose acquisition company Deep Medicine Acquisition Corp, remains committed to accelerating its growth while better meeting the needs of its broader and rapidly growing audience by ensuring that every consumer’s experience with its indoor golf simulators is excellent. This is in addition to generating additional value for its shareholders.

TruGolf (TRUG), closed Wednesday's trading session at $1.44, off by 1.9074%, on 48,121 volume. The average volume for the last 3 months is 9.154M and the stock's 52-week low/high is $1.11/$19.91.

C3.ai Inc. (AI)

reported earlier on C3.ai Inc. (AI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Last week, the European Commission set up a new AI office that will focus on drawing up and implementing policies for the bloc. The office, which will also serve as an international reference point, will support the development and use of trustworthy artificial intelligence and protect against risks.

In a statement posted on its site, the commission noted that the AI office formed the foundation for one European artificial intelligence governance system. It added that the office promoted an innovative ecosystem of trustworthy artificial intelligence and would ensure a coherent and effect approach on AI at the global level. In addition, the office will work with difference experts, institutions and stakeholders, including a panel of experts to ensure strong links to the scientific community, to accomplish various tasks.

The European Commission first announced its AI strategy in 2021. The AI office will focus on supporting governance bodies in member states while also coordinating policy between them.

During the first AI safety summit last year, the Bletchley Declaration was signed by 28 countries, including the United Kingdom, China and the United States. The declaration centers on building risk-based policies across nations to ensure AI safety and the identification of AI safety risks.

Europe has also released the European Union AI Act, a comprehensive law on artificial intelligence. The European Parliament announced that artificial intelligence developed within member states should remain transparent, safe, nondiscriminatory, traceable and environmentally friendly. Safety in the use and development of artificial intelligence has remained a concern since the public was introduced to how technology could transform on such a scale.

In an effort to manage this development, the European Commission also launched the GenAI4EU initiative, which will focus on supporting small and midsize enterprises as well as startups in ensuring that any new artificial intelligence project respects the European Union’s rules and values.

Additionally, commission president Ursula von der Leven recently announced a new initiative that would make supercomputers in Europe available to innovative startups. She also launched a competition that would award prize money to companies that developed new artificial-intelligence models under open-source licenses for noncommercial use.

In the United States, the U.S. Artificial Intelligence Safety Institute was established under the National Institute of Standards of Technology following the safety summit last year. The institute will facilitate the development of standards for security, safety and testing of artificial intelligence models.

The establishment of entities to provide guidelines that AI companies such as C3.ai Inc. (NYSE: AI) can follow as they bring to market various products and solutions will help address some of the concerns that some sections of the population have about these new technologies.

C3.ai Inc. (AI), closed Wednesday's trading session at $30.37, off by 1.0104%, on 3,980,222 volume. The average volume for the last 3 months is 23.657M and the stock's 52-week low/high is $16.79/$48.87.

Canaan Inc. (CAN)

reported earlier on Canaan Inc. (CAN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Crypto and investment frauds rank as the most perilous schemes in the United States presently, according to the Better Business Bureau (BBB). These fraudsters often deceive their victims, resulting in substantial financial losses, as revealed in the BBB’s annual report on the prevalent scams of 2023, compiled from approximately 67,000 reported incidents.

Last year, around 80% of U.S. citizens targeted by crypto fraud experienced monetary losses, with the median amount being $3,800. However, the losses incurred in crypto scams frequently exceed this figure significantly, according to CBS News’ Anna Werner, who specializes in consumer investigations.

Perpetrators of such scams utilize various platforms, including text messages, social media and gaming apps, to approach potential victims, boasting about financial success through crypto investments. Subsequently, once a victim replies, these perpetrators pivot the conversation toward convincing victims to engage in purchasing, trading or storing digital assets on fraudulent wallets and exchanges.

Cryptocurrency, being an unregulated investment domain, has long been flagged by consumer advocates and federal regulators as susceptible to fraudulent activities. The surge in its popularity during the pandemic, fueled by curiosity among investors, has led to substantial investments in cryptocurrencies such as Solana, Bitcoin and Ethereum. Presently, the industry boasts a market cap of $2.65 trillion, as reported by Forbes.

However, the allure of cryptocurrency investments comes with inherent risks. Instances abound where seemingly legitimate companies, such as FTX, once among the biggest cryptocurrency exchanges in the world, have collapsed dramatically. FTX’s downfall in 2022, marked by an $8 billion fund shortfall and allegations of misappropriating customer funds by former CEO and founder Sam Bankman-Fried, serves as a cautionary tale.

Furthermore, billions have been lost by cryptocurrency investors as a result of cyberattacks and fraud. One case in point is the lawsuit brought by a 70-year-old woman from California against Chase Bank, where she lost $720,000 as a result of falling for a cryptocurrency fraud.

The BBB’s report also identifies employment fraud as the second most prevalent financial risk in 2023. In these schemes, scammers deceive victims into believing they’ve secured employment and solicit personal information under the guise of completing onboarding formalities. The median loss in employment scams last year amounted to $1,995.

Additionally, the BBB ranks online purchase fraud as the third most dangerous. Usually, victims fall victim to bogus websites, where they try to buy things but receive get them. In these types of frauds, the average loss was $71.

Crypto companies across the board, including crypto mining entities such as Canaan Inc. (NASDAQ: CAN), are aware of this threat and are implementing measures to curb hackers and limit other wrong elements.

Canaan Inc. (CAN), closed Wednesday's trading session at $1.37, off by 1.4388%, on 14,461,353 volume. The average volume for the last 3 months is 42.529M and the stock's 52-week low/high is $1.13/$3.50.

Rivian Automotive Inc. (RIVN)

reported earlier on Rivian Automotive Inc. (RIVN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Last week, Rivian Automotive Inc. (NASDAQ: RIVN)’s shares closed about 2% higher following the launch of its new SUV. Rivian is an electric-vehicle manufacturer and automotive-technology and outdoor-recreation company backed by Amazon.com.

Within hours of its launch, the company received thousands of reservations, which fueled optimism that Rivian could occupy a larger share of the EV market. In a post on X, Rivian CEO RJ Scaringe stated that the company had seen more than 68,000 reservations for the R2 SUV.

The vehicle’s starting price is $45,000, and the EV boasts an estimated range of 300-plus miles. Its charging system allows for fast charging with CCS or NACS, which means owners can use Tesla Superchargers or the Rivian Adventure Network. The spacious vehicle also has fold-flat seats and a thoughtfully designed interior.

The company plans to produce its R2 SUV at its American factory while halting construction at its second factory in Georgia, which may save on costs. Compared to its previous forecast, the company projects that pausing the construction will drive additional savings of more than $2.25 billion for the company. In addition, the pause will expedite R2 deliveries to the first six months of 2026.

Emmanuel Rosner, a Deutsche Bank analyst, stated that cost savings will leave Rivian with enough cash on hand through start of production for the R2, which will relieve significant pressure to raise capital in the short-term.

The company announced last week that once R2 production begins, its Illinois plant would produce 215,000 vehicles annually. Rivian manufactures electric delivery vans at the same plant.

Bank of America analysts added that with the launch of the R2, the auto manufacturer could break into the mass-market segment, which makes up almost one-half of total automotive sales in America. In a surprise move, the company also revealed its R3 vehicle and a variant of the same during the R2 launch. The R3 should be launched soon and will be more affordable than the R2.

The announcement comes at a time when the demand for electric vehicles is increasing but at a slower pace than auto manufacturers expected. Prior to the launch last week, the company’s stock had nearly halved in value. Since the launch, its market value has risen by more than $1.7 billion.  The automaker’s market value recently stood at about $12.4 billion.

In other news, Tesla is also looking into more affordable vehicle models, and the launch of the R2 gives Rivian an edge over its more established competitor.

Rivian Automotive Inc. (RIVN), closed Wednesday's trading session at $11.71, off by 5.3355%, on 37,043,047 volume. The average volume for the last 3 months is 124,847 and the stock's 52-week low/high is $10.05/$28.06.

The QualityStocks Company Corner

Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF)

The QualityStocks Daily Newsletter would like to spotlight Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) .

Investments in gold have spiked recently, for good reason. Inflation is affecting the value of the dollar while high rates and market volatility are causing economic uncertainty in different parts of the globe. In such times, investors traditionally flock to gold as a safe haven. This isn't the only thing driving interest in the precious metal either. The recent price of gold has seen steady growth, with spot price reaching $2,160 an ounce. Investors are advised to seek gold for stability, especially because it doesn't rely on third-party obligations. With an unusual economic climate and uncertainty all around, one would do well to include the precious metal in their portfolio. For those investors who aren't keen on buying physical gold, stocks of gold exploration entities such as Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) can offer an alternative, although adequate due diligence is a prerequisite if one is to benefit from holding any stocks.

Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) is a leading gold explorer in the Guiana Shield, South America. In early 2021, the Company announced an exciting new greenfield gold discovery at its Oko West project in Guyana, where, after 22 months of resource definition drilling, the Company has announced an initial Mineral Resource Estimate (MRE) containing 2.475 Moz of gold in Indicated resources at 1.84 g/t and 1.762 Moz of gold in inferred resources at 2.02 g/t contained within a pit shell outline. Preliminary metallurgy results performed by the company, consisting of 8 bottle roll tests obtained strong results, averaging just under 90% recoveries on average. The Company is continuing with additional development activities at Oko West, including environmental base line studies and additional metallurgical work relating to the delivery of a PEA by year end 2023. In addition, Reunion Gold is currently exploring several priority targets in the Oko West project area on which the company feels there is good potential to add additional resource ounces. This includes the opportunity to grow the initial mineral resource estimate (MRE) released on June 13, 2023, and to discover additional gold ounces at Oko West outside of the resource area.

The Guiana Shield remains one of the most prospective exploration locations globally for the discovery of world class orogenic gold deposits. The shield, including both Guyana and Surinam, contain large relatively underexplored greenstone belts, from which Reunion Gold expects many more significant gold discoveries could emerge in the coming years.

Oko West Project

Reunion Gold’s Oko West Project is a brand-new gold discovery in northwest Guyana located within the historical Oko gold district. Alluvial gold has been mined from the Oko district since the turn of the century, but very little primary gold has been mined or even explored for to the best of the company’s knowledge. The project comprises a prospecting license with an area of approximately 44 square kilometers and is 100% held by Reunion’s Guyanese subsidiary.

In 2020, Reunion Gold’s geochemical survey, trenching and initial 1000 m drill program discovered and confirmed the presence of gold mineralization in this Orogenic gold system. The gold occurs in the eastern edge of the project area, along a 6km long sheared contact between a granitoid intrusion and a meta volcanic-meta sedimentary rock package. The MRE is located within the Kairuni zone, which represents the northern most 1.9 km of the 6 km long contact.

“We are advancing our Oko West project along two tracks. The first is to advance the exploration programs outside of the Kairuni zone, aimed at outlining and discovering additional gold mineralization within our Prospecting License. On this front, I am very excited by the results from the initial Scout RC Geochem drill program that is defining new targets west of our Kairuni zone,” Rick Howes, President and CEO of Reunion Gold, stated in a recent news release. In addition to the targets west of the Kairuni zone, the company has also commenced exploration work on the southern ~ 4 km of the same sheared contact that hosts the Kairuni zone MRE. In addition, the company feels that the MRE marks the size of the Kairuni resource at a point in time and that there is good potential to continue to grow the resource. The MRE remains open at depth below the resource pit outline in the block 4 area and also to depth and along strike in the block 5 and 6 areas. In addition to the exploration programs, the second strategic track is to rapidly advance the Kairuni zone along the path to development. To that end the company is moving forward with the engineering and other studies, including more detailed metallurgical studies, that will support the release a PEA on the Kairuni zone by year end 2023 The company feels that the rapid advancement of development of Kairuni zone MRE, while in parallel continuing to explore for additional ounces on the project, is the best path to try and maximize shareholder value in the shortest period of time.

Guyana

Guyana boasts a long history of mining gold, bauxite, diamonds and manganese. Still, the greenstone belts of the Guiana Shield remain relatively unexplored when compared to the analogous regions of the West African Shield (Birimian), which, according to geological evidence, was once connected to the Guiana Shield, forming a contiguous craton prior to the Mesozoic period.

Despite a historical lack of accessibility and low exploration intensity, several significant large-scale projects have emerged in the Guiana Shield, including Aurora, Oko West, Oko Main, Toroparu and Omai. Guyana is English speaking with a British based parliamentary and legal system and boasts the world’s fastest growing economy on the back of significant offshore oil discoveries by Exxon and its partners. It is expected that a significant amount of the revenues from oil production will be invested in improving the infrastructure, education and health care and agriculture within the country.

Market Opportunity

The World Gold Council, an industry association representing gold producers with hundreds of mining operations in nearly 50 countries around the world, called 2022 the “strongest year for gold demand in over a decade.” Annual gold demand jumped 18% YoY due to “colossal central bank purchases, aided by vigorous retail investor buying and slower ETF outflows.”

Despite this spike in demand, total annual gold supply increased by just 2% in 2022, halting two years of successive declines but failing to challenge 2018 highs. This supply-demand imbalance could provide a favorable market environment as Reunion Gold continues to advance drilling programs at its 100%-owned Oko West Project.

Management Team

Successful exploration and the discovery of significant deposits in any given region require immense amounts of local knowledge and experience. This is the principle around which Reunion Gold has built its management team. In total, the company’s leadership boasts over 225 years of combined experience in the Guiana Shield.

David Fennell is the Executive Chairman of Reunion Gold, a position he has held since the company’s inception in 2003. He has 40 years of experience in the mining industry. He received a law degree from the University of Alberta in 1979 and practiced law until he founded Golden Star Resources Ltd. in 1983. During his term as President and CEO, Golden Star became one of the largest and most successful exploration companies. While at Golden Star, he was instrumental in the discovery and development of the Omai Gold Mine in Guyana and the Gross Rosebel Mine in Suriname. In 1998, Mr. Fennell became Chairman and CEO of Hope Bay Gold Corporation. He held this position through the merger of Hope Bay and Miramar Mining Corporation and remained as Executive Vice-Chairman and Director for the combined entity until its takeover by Newmont Mining Corporation in 2008. Mr. Fennell is currently a member of the board of directors of G Mining Ventures Corp. and Sabina Gold & Silver Corp.

Rick Howes, P.Eng., is the company’s President and CEO. He is a seasoned mining executive with over 39 years of experience in the mining industry, most recently as CEO of Dundee Precious Metals. Mr. Howes has extensive operating, technical and project development experience in both underground and open pit mines throughout Canada and internationally. In 2009, Mr. Howes joined Dundee Precious Metals, where, as VP and General Manager, he led the transformation of the Chelopech Mine in Bulgaria to reach world-class levels of performance. He became COO in 2011 and oversaw several significant growth capital development projects, including the expansion of the Chelopech Mine, the upgrade and expansion of the Tsumeb Smelter in Namibia and the development of the greenfield Ada Tepe open pit gold mine in Bulgaria. He was appointed CEO in April 2013, leading Dundee’s transformation from a junior gold producer to a multi-asset mid-tier gold producer generating strong free cashflow and solid returns to shareholders. Mr. Howes has been recognized as a visionary leader in mining, organizational innovation and transformation and was recognized as the Outstanding Innovator of 2016 by the International Mining Technology Hall of Fame.

Alain Krushnisky is the CFO of Reunion Gold. He brings to the company years of experience in the mining sector, including 10 years with Cambior Inc. (now IAMGOLD) in capacities such as Vice-President and Controller. Since 2004, Mr. Krushnisky has been doing consulting work for various publicly listed exploration and mining companies. He graduated from the University of Ottawa in 1983 with a bachelor’s degree in commerce and is a Chartered Professional Accountant.

Justin van der Toorn is the company’s VP Exploration. He is an exploration geologist with 18 years’ experience in the minerals industry, leading and managing exploration teams from grassroots activities through to discovery and resource definition drilling. Mr. van der Toorn’s previous experience has been in a range of commodity and deposit styles, including extensive work in Carlin-style gold, low- and high-sulphidation epithermal, porphyry and orogenic gold systems. He holds an MSci degree in Geological Sciences from the Royal School of Mines, Imperial College London. He is registered as a Chartered Geologist (CGeol) of the Geological Society, and a European Geologist (EurGeol) by the European Federation of Geologists.

Doug Flegg is the company’s business Development advisor. Doug has over 35 years’ experience in mining and mining finance with senior positions in research, portfolio management and global equity sales. Previously, Mr. Flegg was Managing Director Global Mining Sales with BMO Capital Markets where he was involved in raising $35 billion in over 200 corporate financings. Since 2016 he has been providing business development, strategic, and financing advice to corporate mining clients. Mr. Flegg also has a B.Sc. in Geology, work experience as a geologist and an MBA from Queens University.

Reunion Gold Corp. (OTCQX: RGDFF), closed Wednesday's trading session at $0.3356, up 0.179104%, on 330,300 volume. The average volume for the last 3 months is 32,063 and the stock's 52-week low/high is $0.24/$0.46.

Recent News

Bravo Multinational Inc. (OTC: BRVO)

The QualityStocks Daily Newsletter would like to spotlightFathom Bravo Multinational Inc. (OTC: BRVO).

The media streaming market was valued at $119.01 billion and is expected to reach $173.73 billion by 2028

Bravo recently announced entering an Asset Purchase Agreement to acquire assets of Streaming TVEE Inc., including the license of OTT (Over-The-Top) streaming technology

TVee NOW(TM) is set for beta launch in Q1 2024 and is expected to be accessible across various devices, with dedicated apps on platforms including Roku, Apple, and Google Play stores

The media streaming market has experienced a strong growth pattern over recent years, fueled by the growing demand for subscription-based services, the increased availability of region-specific and original content, and the popularity of live sports. In 2023, this market was valued at $119.01 billion and is expected to reach $173.73 billion by 2028, growing at a CAGR of 7.86% (https://ibn.fm/TOJAM). The drivers for growth are changing the strategies the vendors adopt in the market – emphasizing enhanced customer experience by providing personalization and affordability. Bravo Multinational (OTC: BRVO), a company actively exploring opportunities in the entertainment, hospitality, and technology sectors to generate long-term value for its shareholders through high-growth business ventures, recently announced entering into an Asset Purchase Agreement to acquire the assets of Streaming TVEE Inc., marking its entrance into the video streaming market.

Bravo Multinational Inc. (OTC: BRVO) actively explores opportunities in the entertainment, hospitality and technology sectors to generate long-term value for its shareholders through high-growth business ventures. Currently focused on pioneering innovative solutions in the digital content landscape, the company’s goal is to provide cutting-edge and diverse content experiences to a global audience.

In February 2024, Bravo finalized a deal to acquire Streaming TVEE Inc.’s assets, marking a pivotal step in establishing its flagship offering, aptly named TVee NOW™. The acquired assets provide the company with the technology and foundation to soon offer streaming services including Video-On-Demand (VOD) and linear TV, often referred to as traditional broadcast TV, which encompasses cable and satellite networks, through a joint venture with Pythia Experiences.

TVee NOW™ plans to offer a wide range of on-demand content, including movies, series, concerts and original programming, at minimal or no cost to viewers. The service, set for beta launch in Q1 2024, will be accessible across various devices, with dedicated apps available on platforms such as Roku, Apple and Google Play stores, reinforcing Bravo’s commitment to innovation and audience accessibility.

The company is based in Virginia Beach, Virginia, with a second office soon opening in Las Vegas, Nevada.

Products

TVee NOW’s streaming service will offer a portion of its content for free, catering to the growing demographic of cord-cutters and aligning with the dynamic landscape of advertising-based video on demand (AVOD) streaming. Bravo’s Over-The-Top (OTT) streaming platform is specifically crafted to deliver content directly to viewers via the internet, accessible through a browser or freely downloadable apps on smartphones, tablets and smart TVs.

Bravo’s planned strategic approach for content is to first integrate partnered Free Ad-Supported TV (FAST) channels, programmatic advertising and a tiered revenue sharing model. Additionally, the company plans to complete the deal with Pythia Experiences, enabling a hybrid model comprised of AVOD, utilizing programmatic advertising through ad servers, and Subscription-based Video-on-Demand (SVOD), which the company plans to offer at competitive rates compared to other services. With this model completed, Bravo can bridge the gap until the company can ultimately create its own original content.

Through the asset purchase agreement with Streaming TVEE, Inc., the company obtained exclusive rights, image and likeness, label waivers and exploitation rights for streaming of 117 high-definition music and comedy performances, each offering a director’s cut and multiple camera perspectives. Some of the music artists include Snoop Dogg, H.E.R., Kings of Leon, Alicia Keys and Bone Thugs-N-Harmony, along with comedic performances from Bill Burr, Jim Gaffigan, Kristen Schaal, Rob Delaney and others. This original footage will allow Bravo to recreate shows in diverse formats, which can showcase these concert films in a compelling full-feature format.

Market Opportunity

A report from Fortune Business Insights, a global market research and reporting firm, estimated the global video streaming market at $455.45 billion in 2022. It is projected to grow from $554.33 billion in 2023 to $1.9 trillion by 2030, achieving a CAGR of 19.3% during the forecast period.

Growth drivers, according to the report, include a rising number of users of Video-on-Demand services (YouTube, for example) worldwide and the growing adoption of OTT content providers (like Netflix and Hulu, among many others) by consumers, as well as consumers’ willingness to spend more for streaming video content.

Management Team

Grant Cramer is CEO and Director of Bravo. He has more than 30 years of experience as an actor, writer, director, producer and production executive. As founder and president of Landafar Entertainment and Global Pictures Media, he has overseen development and production of 14 feature films. He executive produced Lone Survivor, November Man and Arctic Dogs. He produced And So It Goes, directed by Rob Reiner and starring Michael Douglas and Diane Keaton. His short film Say Goodnight, Michael won several awards, including the Grand Jury Award at the New York International Independent Film Festival.

Frank Hagan is Bravo’s President and Director. He is an Emmy-nominated producer with over 30 years of experience in the entertainment industry. He is the former Programming Director and GM of QTN. He has produced shows for major networks and companies, including Discovery Channel, History Channel and Relativity Media. Most recently, he served as a consulting producer for Electric Entertainment’s ElectricNOW! and the Saturn Awards and worked as a regular weekly panelist for Outlaw Internet Radio.

Richard Kaiser is CFO and Director of Bravo. He is also CFO at BioForce Nanosciences Holdings Inc. and Gold Rock Holdings Inc. He serves on the board of Element Global Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings Inc. He previously directed investor relations for Royal Standard Minerals Inc. and Scorpio Mining Inc. He was also Head of Corporate Communication and Investor Relations at Air Packaging Technologies Inc. and Puff Pack Industries Inc.

Kayla Slick is COO and Director at Bravo. She has more than 15 years of experience in various industries, including finance, healthcare, technology, retail, hospitality and entertainment. She co-founded The PRIME Symposium and significantly increased revenues for INSIDE Public Accounting. She held positions at Interactive Digital Solutions, where she founded the Sales Development Program and was later promoted to Marketing Communications Director for IDS’ flagship virtual patient observation product.

Bravo Multinational Inc. (OTC: BRVO), closed Wednesday's trading session at $0.24, up 9.0909%, on 4,750 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.46/$.

Recent News

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF)

The QualityStocks Daily Newsletter would like to spotlight Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF).

Several climate groups across the globe were left reeling after four of the largest banks in the United States abandoned key industry safeguards and standards that sought to address the social and environmental risks posed by financial institutions when they invest in mining and fossil fuel projects. Dubbed the Equator Principles, these industry standards have been around for more than two decades and create a simple environmental-standards framework for addressing financial deals involving extractor projects that cause pollution. Although the standards aren't enforceable, the majority of banking institutions worldwide agree to abide by the standards to help mitigate the existential threat of climate change. Even so, the exit indicates a growing trend among U.S.-based financial institutions of backpedaling climate-change, green-energy and social-responsibility commitments. Several Republican-led states have also begun boycotting investors and banks that incorporate environmental, social and governance ("ESG") into their investment strategies. Despite the backlash against ESG implementation and investing, there is a growing number of companies such as Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) that are taking on the challenges of doing business in a way that is not only profitable but is also responsible and sustainable from an ESG point of view.

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) is a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space. The company aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications.

Reflex Advanced Materials is based in Vancouver, British Columbia. Its project portfolio includes the Ruby Graphite Deposit in Montana and the ZigZag Lithium Property in Ontario.

Projects

Ruby Graphite Project

Located in a mining-friendly jurisdiction in southwest Montana, the Ruby Graphite Deposit is a low cost, rapid re-entry opportunity that produced roughly 2,400 tons of graphite from 1902 to 1948. Reflex Advanced Materials holds mining rights for 755 hectares at the Ruby Graphite Project, with 96 federal lode mining claims. Recent samples assay at 95.8% to 98.4% total carbon.

The site is notable as the only combined U.S. graphite flake and vein graphite source. Vein graphite is ideal for energy storage applications, because it requires fewer steps to achieve purity than synthetic alternatives and is therefore far less environmentally damaging. This is expected to play a key role in the project’s development as demand for electric vehicles continues to surge.

In March 2023, the company announced its submittal of permit applications to the Bureau of Land Management in respect of its exploration of the Ruby Graphite Project. Its initial drill program, expected to take place in the summer of 2023, includes plans for 3,500 total meters of drilling, cored to an average depth of 130 meters. The targets for this drill program have been identified using historical data from original mine operations and data gathered for the initial 43-101 technical report on the project, dated January 31, 2023.

ZigZag Lithium Property

Located in the Thunder Bay Mining Division of Ontario, the ZigZag Lithium Property consists of eight mining claims spanning roughly 2,710 hectares. Mineralization at the property, most notably lithium, is based in pegmatite dikes and concentrated in spodumene crystals, which are consistent throughout the entire unit.

Spodumene is readily observable in outcrops and in drill cores, with crystal sizes ranging from 3-15cm, on average.

Reflex Advanced Materials and American Energy Technologies Company Metallurgical Partnership

Reflex Advanced Materials has entered into a material processing agreement with American Energy Technologies Co., which is based in Arlington Heights, Illinois, to conduct metallurgical testwork with the goal of creating a technical support data package for Reflex’s target customer base, U.S. Federal agencies and qualification programs with hi-tech customers in the battery and battery storage business.

The resulting coated, spherionized, purified graphite (CSPG) material that is expected to be created from the aforementioned tests will be used to provide potential customers of CSPG with samples so that they can begin the material qualification process.

Market Opportunity

Graphite is an ideal battery anode and has dominated the market since the proliferation of lithium-ion batteries. Despite this demand, there is currently no significant production of lithium-ion battery anode material in North America.

Instead, most graphite sold in North America today is sourced from Chinese producers. U.S. President Joe Biden highlighted this sourcing disparity in a 2022 address:

“The United Stated depends on unreliable foreign sources for many of the strategic and critical materials necessary for the clean energy transition – such as lithium, nickel, cobalt, graphite and manganese for large-capacity batteries,” he said. “Demand for such materials is projected to increase exponentially as the world transitions to a clean energy economy.”

The U.S. Department of Energy is in the process of awarding $2.8 billion to expand domestic manufacturing of batteries for electric vehicles and combat this foreign dependency. Reflex Advanced Materials has identified its Ruby Graphite Project as a prime candidate for U.S.-sponsored initiatives due to the rarity and scarcity of natural graphite deposits in the country.

Processing graphite domestically in the U.S. is expected to provide Reflex Advanced Materials a competitive advantage as manufacturers begin to seek out American supply in the face of increased diplomatic tension. This is critical, as a rise in anode demand is expected to fuel a shortage of 8 million tonnes of graphite by 2040. World Bank Group projects 494% growth in total graphite demand by 2050.

Leadership Team

Paul Gorman is the CEO and a Director of Reflex Advanced Materials. He brings to the company over 25 years of experience in junior mining finance, public listings, viability assessment and operational rationalization. For 18 years, Mr. Gorman served as president and managing partner of Riverbank Capital, where he played an instrumental role in raising more than $85 million for small-cap companies. In 2008, he funded Industrial Minerals Inc. (later Northern Graphite) and served in an advisory role for four other graphite companies, contributing significantly to the revitalization of the junior graphite space in North America. Mr. Gorman founded Mega Graphite Inc. in 2009 and has served as chief executive for three other companies.

Tasheel Jeerh, CPA, is the company’s CFO. He is a finance and accounting professional with over a decade of experience spanning both public and private sectors. Prior to joining Reflex Advanced Materials, Mr. Jeerh played a pivotal role in the growth of a private upstream oil and gas firm, dealing with over $2 billion in M&A activity and $1 billion in financing activities. He gained his designation at PricewaterhouseCoopers, where he worked as a manager in the assurance practice.

Greg Bell is Project Manager for Reflex Advanced Materials. He is a multi-disciplined engineering management professional with more than 40 years of experience in the natural resources sector. Mr. Bell has successfully built and managed several start-up operations in various capacities. He has been active in graphite and lithium exploration for the past seven years.

Christopher W. Hill leads the company’s Corporate Development initiatives. He is an investor and entrepreneur with over a decade of experience in the capital markets. Mr. Hill began his career as an investment advisor and then began to consult and advise private companies on their paths to becoming publicly traded. He specializes in corporate development and strategic financing utilizing his large network in the capital markets.

Reflex Advanced Materials Corp. (RFLXF), closed Wednesday's trading session at $0.125, up 10.7174%, on 19,302 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0648/$0.72.

Recent News

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF)

The QualityStocks Daily Newsletter would like to spotlightFathom Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF).

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) recently announced that on Feb. 29, 2024, it entered into a binding letter agreement with Emerald Geological Services ("EGS") under which it has been granted an option to acquire an undivided 80% beneficial interest in a property owned by EGS in Nunavut, Canada. "We are very excited to option the Epworth Property," said Thomas Ullrich, CEO of Aston Bay. "This is an impressive 74-kilometre-long trend of high-grade copper, silver and zinc mineralization with accompanying gold, cobalt and lead. This mineralization is in a style typical of the Central African Copper Belt that boasts several large, high-grade deposits. We have similar mineralization at our Storm Project and look to leverage our knowledge and experience gained there to make new discoveries at Epworth."

To view the full press release, visit https://ibn.fm/KgDgi

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) is a publicly traded Canadian minerals exploration company focused on exploring high-grade copper and gold deposits in North America. The company owns the Storm Copper Project and the Seal Zinc Deposit in Nunavut, Canada, and is currently exploring the Buckingham Gold Vein and critical metals prospects in central Virginia. Aston Bay is also in the advanced stages of negotiation on other properties with high-grade critical minerals potential in these areas.

The company believes in responsible exploration and carries out its work programs to the highest standards of social responsibility, environmental stewardship and health and safety. Aston Bay cares about leaving a net positive impact on the communities in which it works and engages with local representatives, Indigenous groups and government agencies to build respectful relationships through dialogue and collaborative processes. Depending on the stage of exploration, these efforts may include employment, contracting, training, community benefits and other agreements.

Aston Bay conducts exploration through safe, socially and environmentally responsible and sustainable work practices. The company embeds core values of health and safety throughout its operations by adhering to strict health and safety standards and practices that meet and/or exceed industry standards and government codes and regulations.

The company is headquartered in Toronto.

Projects

Storm Copper

The high-grade Storm Copper Deposit is located 112 kilometers south of the community of Resolute Bay, Nunavut, on western Somerset Island, just south of the past-producing Polaris Pb-Zn Mine. The property comprises 173 contiguous mining claims, including the Storm Copper and Seal Zinc projects, covering an area of approximately 541,795 acres.

The property has good access to established shipping lanes, and the landscape provides favorable conditions for development of roads and a protected deep-water port. Exploration is supported through excellent infrastructure in the nearby hamlet of Resolute Bay.

Aston Bay is partnered with American West Metals (ASX: AW1) at Storm. American West is responsible for all exploration expenditures, having aggressively advanced the project toward production and earned an 80% interest. This affords excellent optionality to the company’s shareholders, as Aston Bay is free carried with no required expenditures until the completion of a bankable feasibility study.

American West recently completed an Australian JORC-compliant Maiden Resource Estimate for Storm; the North American 43-101 compliant resource estimate is expected in Q1 2024. American West is cashed up and plans a multimillion-dollar resource expansion and new discovery drilling program for the summer of 2024.

The Buckingham County Gold Project

The gold-bearing system at the Buckingham County Gold Project in Virginia lies within a belt hosting past producing mines, current gold mines and advanced gold explorations, stretching through Georgia, the Carolinas, Virginia, Nova Scotia and Newfoundland.

Buckingham hosts a “Kirkland Lake-style” high grade gold vein returning values consistently over one ounce gold per ton and is underexplored both at depth and along almost one mile of strike length. These types of veins have excellent ESG qualities, as they are typically mined using a small footprint underground method, with gold extracted using simple and environmentally friendly gravity methods.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

A report from Acumen Research and Consulting, a global provider of market intelligence and consulting services, valued the global copper market at $304.1 billion in 2022 and forecast that it will reach a market size of $496.8 billion by 2032, growing at a CAGR of 5.1% over the forecast period.

The report identifies a growing demand for copper in the electronics industry, as well as an expanding copper supply due to increasing production from existing mines and the rising number of mine development projects in developing nations, as driving factors in the rising value of the copper market.

Management Team

Thomas Ullrich is CEO and Director of Aston Bay. He has over 30 years of experience in mineral exploration and geoscience. Before joining Aston Bay, he was Chief Geologist North America for Antofagasta Minerals plc, investigating copper potential through extensive property evaluations and management of drill programs in the United States, Mexico and Canada. Prior to that, he was Senior Geologist for Almaden Minerals.

Sofia Harquail handles Investor Relations and Corporate Development at Aston Bay. She has over 15 years of experience in the private and public sectors of the mining industry. Before joining Aston Bay, she worked as a consultant for the Prospectors and Developers Association of Canada and for exempt market dealer Red Cloud Financial Services Inc. Ms. Harquail holds an M.A. from the University of Uppsala in Sweden and received her CPIR designation from the CIRI/Ivey Investor Relations Program. She also sits on the board of the Young Mining Professionals Toronto and is CSC Certified.

Aston Bay has a talented Board of Directors bringing broad experience from across the industry, encompassing resource expansion, mine development, mergers and acquisitions, and mining finance.

Ms. Jessie Liu-Ernsting has over 15 years of experience in the mining industry, spanning capital projects engineering, debt capital markets, private equity and corporate strategy at several firms, including Hudbay Minerals and Resource Capital Funds. She is currently VP Investor Relations and Communications at G Mining Ventures Corp.

Mr. Jeffrey R. Wilson has over 25 years’ experience in the mining industry, having served as a director, officer and advisor of multiple public and private companies in the mineral exploration and mining investment industries. Mr. Wilson is currently President & CEO of Precipitate Gold Corp.

Mr. Gary O’Connor has over 40 years of diverse experience as a mineral exploration and development professional in the management of successful resource projects as well as the evaluation, technical due diligence, and supervision of large mineral exploration and development projects through-out the world. While with Freeport, Mr. O’Connor worked on the due diligence and discovery of a major gold fraud on the Busang gold “deposit” in Kalimantan by Bre-X.

Mr. Mark J. Pryor is a geologist with a 40-year track record of successfully advancing multiple precious metal, copper, coal, REE and Li projects from discovery through to exploitation. He is currently Executive Vice President of the Exploration Division at The Electrum Group.

Aston Bay Holdings Ltd. (OTCQB: ATBHF), closed Wednesday's trading session at $0.1149, up 6.7844%, on 4,661 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0178/$0.2474.

Recent News

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0)

The QualityStocks Daily Newsletter would like to spotlight Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0).

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a leading Swiss-hosted secure and private communications platform, today outlined solutions to protect enterprise and small to medium-sized business ("SMB") owners from the growing menace of bad actor cyber threats. Recent incidents, such as the alleged exploitation of Google accounts via OAuth2 functionality and the high-profile hacking of Microsoft's corporate network from a Russian hacking group, highlight the crucial need for robust cybersecurity and data privacy measures. "As bad actor states continue to escalate their cyber threats, especially in the USA and during a presidential election year, businesses are facing unprecedented risks and soaring costs, as these rogue states and bad actors are doing everything to disrupt the U.S. economy," said Alain Ghiai, the CEO of Sekur Private Data Ltd.

"At Sekur, we provide robust solutions that safeguard sensitive data, empowering SMBs, enterprises and governments to stay one step ahead of these evolving threats and challenges. We are happy to be able to provide these solutions, as we can offer the only Swiss-hosted, proprietary, private and secure communications platform that does not rely on big tech infrastructure, open-source coding or data mining, therefore reducing exponentially the risk of cyber penetration. Our prime directive is to provide private and secure communications for everyone, by offering a truly independent, private and secure means of communications, without any data mining, through our proprietary technology and our secure private servers based in Switzerland."

To view the full press release, visit https://ibn.fm/8XgxX

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0) is a Cybersecurity and Internet privacy provider of Swiss hosted solutions for secure and private communications. The company distributes a suite of encrypted e-mails, secure messengers and secure communication tools. Sekur Private Data Ltd. sells its products through its own website at www.Sekur.com, approved distributors, and telecommunications companies. Sekur Private Data Ltd. serves consumers, businesses and governments worldwide.

Customer information is completely confidential and safely stored in Switzerland using military grade security. All data, whether physical, network-based or encryption security, is stored in bank-approved, state-of-the-art ISO-certified data centers used by Swiss and global banks and most United Nations organizations, as well as many corporations and governmental organizations. All user data is protected by the Swiss Federal Data Protection Act and the Swiss Federal Data Protection Ordinance, which offer some of the strongest privacy protection in the world for both individuals and organizations.

The company owns 100% of its own infrastructure and, unlike its competitors, does not rely on third party cloud services like Amazon Web Services, Microsoft Azure Cloud or Google cloud infrastructure.

Sekur Private Data has chosen Switzerland to locate its data storage because of the country’s neutrality, independence, strong privacy laws, long standing political stability and excellent international relations. Switzerland is also home to several large multinational corporations and is ranked as having one of the strongest and most competitive economies in the world.

The company is headquartered in Toronto, Ontario.

Products

Sekur Private Data distributes a privacy communications suite offering encrypted and private email, the only Swiss-hosted privacy VPN, and a secure and private messaging application. All solutions cater to consumers, SMBs, enterprises and governments.

  • SekurMail® is an encrypted email service offering a private, safe and powerful tool to communicate with everyone, either within the Sekur ecosystem or outside. SekurMail protects personal information and communications from being accessed by unauthorized parties. Its encryption and other security measures prevent messages from being intercepted, modified or tampered with, either in transit or while stored. SekurMail empowers the client to access information and communicate with anyone in the world, regardless of geographical or political barriers.
  • SekurVPN® creates a secure, encrypted connection between the client’s device and the Internet, giving clients access to the web safely and privately by routing their connections through a server and hiding their online actions. All the data sent and received is hidden from prying eyes. This includes the clients’ Internet Service Providers, as well as potential hackers and even government surveillance agencies. It can also help clients bypass geographical restrictions and censorship.
  • SekurMessenger® is a Swiss-hosted private and secure messaging communications app providing secure and private chat, self-deleting chat, voice recording and file transfer via any mobile device, tablet or desktop computer. Communications are transmitted only within secure servers. It’s designed for organizations that need to protect their flow of information and secure their communications with customers and partners. SekurMessenger is designed to provide military-grade encryption and privacy by ensuring that only the sender and intended recipient can read the messages exchanged. It works for both licensed users of the app and intended message recipients who do not have the app.

Market Opportunity

An analysis from ReportLinker forecasts that the global cybersecurity market will grow from an estimated $173.5 billion in 2022 to $266.2 billion by 2027, recording a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors that are driving cybersecurity market growth, according to the report.

The global data privacy software market was estimated to be worth $1.68 billion in 2021 and is expected to grow from $2.36 billion in 2022 to $25.85 billion by 2029, achieving an eye-popping 40.8% CAGR during the forecast period, according to a Fortune Business Insights report titled ‘Data Privacy Software Market 2022-2029’.

The widespread shift toward remote working culture, evolving government data privacy regulations and the rapidly increasing adoption of Internet-of-Things devices are among the major factors propelling market growth, per the report.

Management Team

Alain Ghiai is founder, CEO and Director at Sekur Private Data. He also founded GlobeX Data S.A. (GDSA) in 2007 and has served as Director and CEO since then. He founded GlobeX Data Inc. (GlobeX US) in August 2012 and has served as Director and CEO since that time. He attended the California College of Arts in San Francisco, where he earned a Bachelor of Architecture. He has over 15 years of experience in the software industry and was instrumental in taking Sekur Private Data public in July 2019.

Scott Davis, CPA, CGA, is CFO at Sekur Private Data. He is also a partner at Cross Davis & Company LLP Chartered Professional Accountants. His experience includes CFO positions at several companies listed on the TSX Venture Exchange. He spent four years at Appleby as an Assistant Financial Controller. Prior to that, he spent two years at Davison & Company Chartered Professional Accountants as Auditor, five years with Pacific Opportunity Capital as Accounting Manager and two years at Jacobson Soda and Hosak, Chartered Professional Accountants. He obtained his CPA, CGA in 2003.

Learn more about the company’s management team by visiting its corporate page.

Sekur Private Data Ltd. (OTCQB: SWISF), closed Wednesday's trading session at $0.0432, up 2.6128%, on 20,520 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0394/$0.1576.

Recent News

Astiva Health

The QualityStocks Daily Newsletter would like to spotlight Astiva Health

Congress has once again failed to halt a physician pay cut that will affect access to high-quality care by patients on Medicare. In a recently struck deal, the House voted to decrease this year's proposed pay-cut for physicians by half, with the Senate expected to vote on the same measure. The need to reform physician payment is dire, with the American Medical Association (AMA) showing that the system in use at the moment is unsustainable. This comes after Medicare physicians received a 2% reduction in their pay in 2023.  In a statement, Jesse M. Ehrenfeld, president of the American Medical Association (AMA) noted that AMA members were disappointed that physician payment cuts under Medicare were allowed to proceed by Congress. Ehrenfeld argued that there was a lot of support as well as many opportunities to stop the Medicare cuts on physician pay that were imposed earlier in the year. The American Medical Association is relentlessly advancing fixes to the current pay system, with a focus on the Strengthening Medicare for Patients and Providers Act (HR 2474). This bipartisan measure will offer doctors a yearly and permanent inflationary payment update in Medicare. The measure is being sponsored by Congressman Dr. Larry Bucshon of Indiana, who stated at the recent AMA National Advocacy Conference that both GOP and Democratic lawmakers know this issue needed to be addressed. As more Medicare physicians become disenchanted with the pay cuts, an increasing load could be imposed upon entities such as Astiva Health that are focused on improving healthcare access and equity to minorities disadvantaged by the existing healthcare system in the United States.

Astiva Health is a dynamic and innovative Medicare Advantage Prescription Drug (MAPD) health plan committed to reshaping the landscape of personalized and comprehensive healthcare. The company offers full medical, drugs, and supplemental benefits for Medicare enrollees, currently serving counties in California, including Orange, San Diego, Los Angeles, Riverside, and San Bernardino. This broad coverage reflects Astiva Health’s dedication to reaching a diverse demographic and addressing the healthcare needs of individuals across Southern California.

Astiva Health primarily serves a heretofore underserved Asian American and Pacific Islander population, which positions it in a critical and expanding market segment and offers substantial growth potential. The company recognizes the diverse needs within its served communities and strives to bridge healthcare gaps through proactive and culturally responsive solutions.

Astiva Health cares about its members and works to establish lifelong relationships with them by providing a tailored approach to healthcare, offering multilingual solutions for customer service, marketing materials and educational resources. Health is an essential key to living a good life, and Astiva Health makes it a priority to help members love the life they live.

The company’s mission is to deliver an unparalleled level of quality care to its members. Astiva Health’s Medicare Advantage plans provide lower costs and additional benefits beyond original Medicare coverage.

Founded in southern California, Astiva Health has strategically positioned itself in a region with a dynamic and diverse population. The organization’s extensive network and culturally responsive approach to healthcare make it well-suited to cater to the needs of the local community, creating a competitive advantage in the market.

The company is based in Orange, California.

Healthcare Model

Astiva Health is not just another health plan. The company considers the uniqueness of its members and, therefore, the means for delivering quality care to each one. To best serve its members, Astiva Health has developed one of the most diverse networks in southern California, offering a selection of medical, drugs, and supplemental benefits including dental, acupuncture, vision and hearing plans tailored to the specialized needs of individual members.

The company’s health plans provide increasing levels of benefits to members in the counties it serves. Astiva Health’s Customer Care Support and representatives are available to assist members with any issues.

The organization’s proactive approach to overcoming language barriers for the Vietnamese communities demonstrates a commitment to inclusivity and enhances accessibility – a key factor for future growth. The successful implementation of strategies for the Vietnamese community sets a precedent for Astiva Health’s ability to adapt and apply similar approaches to serve other ethnic groups in future expansions, broadening the potential impact of its services.

The company provides members access to experienced and dedicated providers and local pharmacies that work together with each member to pave a pathway toward better health. The company’s online directory provides members with a comprehensive list of providers to fit their specialized needs.

Astiva Health collaborates with a variety of partners who offer supplemental benefits to members beyond Medicare. Those benefits include transportation, vision, dental, hearing, fitness, tele-health, acupuncture and chiropractic. Astiva’s forward-thinking strategy not only fulfills a critical societal need but also ensures sustainable growth and transformative impact across diverse communities.

Market Opportunity

Medicare Advantage plans, since their establishment in 2008 as a lower-cost alternative for Medicare enrollees looking to save on monthly premiums, have been one of the fastest growing segments of the health insurance market.

According to a report by healthcare consultant Charts, nearly 31 million beneficiaries are enrolled in a Medicare Advantage plan in 2023, accounting for more than 48% of the total Medicare market. That represents 9.6% enrollment growth over 2022 totals, and the pace of growth is likely to continue, according to the Charts report.
Startup Medicare Advantage plans, a sector that includes Astiva Health, grew even faster for 2023, at a rate of 22% over 2022 totals.

Management Team

Dr. Tri T. Nguyen is co-founder and CEO of Astiva Health. He is a graduate of Stanford Medical School and is a board-certified expert in internal medicine, cardiovascular disease and interventional cardiology. As founder, CEO and owner/operator of Avanta IPA, he is a committed leader in healthcare. His visionary leadership, hands-on experience and deep industry knowledge uniquely position him to guide Astiva to success.

Chi Luong is CFO at Astiva Health. She founded and operates HADD Group LLC, a company managing medical clinic services, including business contracting, finance, staffing and ancillary support for several medical clinics in San Diego. She is responsible for the expansion and daily operation of the business functions of the medical clinics managed by HADD Group, and she has extensive knowledge and experience in healthcare business development.

Viet Tran has over 30 years of experience in engineering research, development and management. He has made numerous contributions to national network security and technology. He led the initial Naval Interoperability Profiles that set a solid foundation for future naval airborne network development. He also led a team of 50 engineers, doctorates and scientists delivering an airborne network system for the Navy’s first carrier-based unmanned aircraft. As Astiva Health’s Chief Operating and Technology Officer, member satisfaction has been his top priority. He is committed to protecting valuable data for Astiva members and providers. He constantly strives for leaner and more effective operations.

Tyler Diep is Vice President, Sales, Marketing and Provider Relations at Astiva Health. His responsibilities include handling special projects for the board of directors, as well as overseeing the sales, marketing and provider relations department. During his tenure, he tripled the membership of Astiva Health. He previously served as councilman and vice mayor of the City of Westminster, California. He immigrated to the U.S. with his parents and graduated from San Diego State with a bachelor’s degree in public administration.

Recent News

chart

Astrotech Corp. (NASDAQ: ASTC)

The QualityStocks Daily Newsletter would like to spotlight Astrotech Corp. (NASDAQ: ASTC).

In 2021, Arizona witnessed the legalization of two long-operating but previously illicit industries: sports betting and recreational cannabis. This change brought a surge of tax revenue to the state, with one industry outpacing the other significantly. While sports betting enjoys greater popularity per capita in the state, it contributes only a small percentage of the taxes compared to the marijuana sector. Representatives of the gaming sector, on the other hand, state that even with its widespread appeal, sports betting only generates marginal returns when contrasted with other gaming options, such as slot machines or board games. When the excessive taxes to which the marijuana industry is subjected reach untenable levels, there could be a domino effect that could result in reduced business opportunities for ancillary companies, such as Astrotech Corp. (NASDAQ: ASTC), that serve verticals within the cannabis industry.

Astrotech Corp. (NASDAQ: ASTC) is an instrumentation company that designs, manufactures and commercializes solutions. Its solutions include mass spectrometry, process controls, chemical detectors and medical disease detection.

The company was established in 1984 and, prior to 2009, was known as SPACEHAB Inc., a NASA contractor offering technology originally developed for NASA to monitor air quality on the International Space Station. When the Space Shuttle program ended, the company focused on its satellite processing and mass spectrometer instrumentation units and adopted the Astrotech name.

In 2014, Astrotech sold its satellite subsidiary to focus on its Astrotech Technology Inc. (ATi) mass spectrometry solutions, which offer a number of advantages over competing platforms. Notably, Astrotech’s ATi technology is ruggedized, rapid, simple to use and customizable, with hands-free calibration and tuning.

Between 2016 and 2019, the company secured U.S. patents for its technology and achieved European Union (ECAC) certification for the TRACER 1000™, the world’s first mass-spec Explosives Trace Detector (ETD) used in airports worldwide. Astrotech continues to innovate and add to its suite of products, including AgLAB-1000, a process control system, and the BreathTest 1000, a disease detection solution.

Astrotech is headquartered in Austin, Texas.

Subsidiaries

Astrotech Technologies Inc.

Astrotech Technologies Inc. (ATi) owns and licenses the platform mass spectrometry technology originally developed by 1st Detect. This technology is designed to be less expensive, smaller and easier to use than traditional mass spectrometers.

Unlike other technologies, ATi works under high vacuum, which eliminates competing molecules, yielding higher resolution and fewer false alarms. The company’s intellectual property includes 18 granted patents, along with extensive trade secrets.

ATi exclusively licenses the Astrotech Mass Spectrometer Technology to the three wholly owned subsidiaries of Astrotech.

1st Detect Corp.

1st Detect Corp. developed the TRACER 1000, the world’s first mass spectrometry-based explosives and narcotics trace detector. 1st Detect ETDs were developed for use at airports, cargo facilities and other secured locations and borders worldwide.

1st Detect’s commercial sales of the TRACER 1000 ETD, consumables and recurring maintenance services brought in $750,000 in total revenue during the fiscal year ended June 30, 2023. The Astrotech subsidiary recently secured two orders for a total of 24 Tracer 1000 units from two Romanian security and telecommunications companies, to be delivered during calendar 2023.

AgLAB Inc.

AgLAB Inc. is developing a series of mass spectrometers for use in the hemp and cannabis market, with an initial focus on optimizing yields in the distillation processes.

AgLAB, which uses the company’s proprietary AgLAB 1000-D2™ mass spectrometer, has been proven to improve distillation oil yields and bottom-line profits for hemp and cannabis producers. During field trials, AgLAB was able to improve ending-weight yields by an average of 24%.

BreathTech Corp.

BreathTech is developing the BreathTest-1000™, a breath analysis tool to screen for volatile organic compound (“VOC”) metabolites found in a person’s breath that could indicate they may have a compromised condition including but not limited to a bacterial or viral infection. The company believes that new tools to aid in the battle against COVID-19 and other diseases remain of the utmost importance to help more quickly identify that an infection may be present.

Market Opportunity

A report by Mordor Intelligence, a research and advisory firm, put the global mass spectrometry market at $6.37 billion in 2023. The market is forecast to grow to $8.63 billion by 2028, achieving a CAGR of 6.25% during the forecast period.

One of the major driving factors for the growth of the mass spectrometry market is technological advancements in mass spectrometer devices, the report states. Key market players are continuously working toward advancing their existing products and launching innovative and advanced mass spectrometer devices.

Another major factor that is expected to boost market growth is increasing research and development expenditure by both government and private entities, according to the report. Mass spectrometry devices are also being used in the detection and analysis of COVID-19 and other disease samples, which may have a positive impact on the market.

Management Team

The Astrotech leadership team includes management executives, as well as industry and technology experts. The company continues to actively expand its talent pool to meet evolving demands.

Thomas B. Pickens III is Chairman, CEO and Chief Technology Officer of Astrotech Corp. He also serves as CEO of Astrotech subsidiaries ATi, 1st Detect, AgLAB Inc. and BreathTech Corp. Previously, he was the founder and president of Beta Computer Systems Inc. and T.B. Pickens & Co. He was founder and general partner of Grace Pickens Acquisition Partners L.P and managing partner of Sumpter Partners. He also served as CEO of Catalyst Energy Corporation and United Thermal Corporation and as president of Golden Bear Corp., United Hydro Inc. and Slate Creek Corp. He received a B.A. in Economics, Computer Science and Engineering from Southern Methodist University.

Jaime Hinojosa, CPA, is CFO at Astrotech Corp. He joined the company in 2015 and has served as its Corporate Controller since 2019. His previous roles with the company include Director of Finance, from 2017 to 2019, and Assistant Controller, from 2015 to 2017. Prior to joining Astrotech, Mr. Hinojosa worked as an Accounting Manager for O’Reilly Auto Parts and gained public accounting experience as an Audit Manager at Burton McCumber & Cortez LLP.

Astrotech Corp. (NASDAQ: ASTC), closed Wednesday's trading session at $8.2, off by 1.2048%, on 6,444 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $7.00/$15.11.

Recent News

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF)

The QualityStocks Daily Newsletter would like to spotlight First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) .

America plans to reduce its emissions by eliminating fossil fuels from energy generation and replacing fossil fuel-dependent technology with alternatives that run on renewable energy. Certain policy measures including the 2022 Inflation Reduction Act (IRA) have reduced clean-energy prices to such a degree that renewables now cost the same as generating energy from combusting fossil fuels. Although making green energy as affordable as fossil-fuel energy is a major step toward achieving a carbon-free economy, a new report has highlighted noncost factors that are slowing down green energy adoption in the United States. After analyzing different modeling scenarios, the Clean Investment Monitor report found that factors such as long grid-connection delays and local opposition to green energy are hampering the rate of the green-energy transition worldwide. As these society-level bottlenecks are worked through, numerous companies such as First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) are working as best they can to avail sufficient supplies of the metals, such as tungsten and copper, needed to enable the green-energy transition.

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) is committed to exploring for and providing essential and critical metals, including tellurium, gold, silver, copper and tungsten, for North American markets. This objective is anchored by the company’s Deer Horn tellurium-gold-silver-copper project in British Columbia, Canada, and further enhanced by its property option on the Klondike tellurium-gold prospect located in Colorado, USA.

First Tellurium’s unique business model is to generate revenue and value through mineral discovery, project development, project generation and cooperative access to untapped mineral regions in indigenous territory with sustainable exploration potential.

The company is headquartered in Vancouver, British Columbia.

Tellurium and the Green Energy Revolution

Tellurium has a key role to play in the ongoing green energy revolution. It is widely used in the manufacturing of photovoltaic cells for solar panels.

Despite this utility, ongoing trade tensions between China and the U.S. create implications for both tellurium and the production of cadmium-tellurium solar cells. Earlier this year, China announced plans to restrict exports of critical metals gallium and germanium, both essential for the production of semiconductors. For reference, China produces around 80% of the world’s gallium and approximately 60% of the world’s germanium.

China’s recent trade restrictions amplify the fragility of the North American tellurium supply, as the Asian nation currently produces about 60% of the world’s tellurium. This sustained supply vulnerability is why First Solar, the United States’ largest solar panel producer, set up a worldwide search for tellurium deposits in the mid-2000s.

“In North America alone, our understanding is that First Solar looked at over a hundred tellurium properties,” First Tellurium CEO Tyrone Docherty stated in a news release. “Their number one property by far, which they acquired, was the Colorado Klondike which we now control.”

The U.S. is now looking to secure safe, domestic sources of tellurium and many other critical metals to pre-empt potential shortages. The Biden administration has instituted a stream of policies, particularly the U.S. Inflation Reduction Act, to source solar components from North America and other “friendly” jurisdictions.

As the only junior mining company in the world focused on tellurium exploration, First Tellurium is ahead of the curve in capitalizing on these initiatives to establish strategic, domestic supplies of key resources for solar panel manufacturers.

First Tellurium’s ESG Initiatives

Through its exploration and partnerships with Fenix Advanced Materials, Cheona Metals and IRMA, First Tellurium strives to generate a measurable, beneficial social or environmental impact alongside a financial return. The company conducts a diversified search for metals, working in alliance with indigenous peoples, NGOs, governments and leading metals buyers. First Tellurium believes this is the future of mineral exploration — generating revenue by exploring responsibly and leveraging diverse partnerships.

First Tellurium proudly adheres to, and supports, the principles and rights set out in the United Nations Declaration on the Rights of Indigenous Peoples and, in particular, the fundamental proposition of free, prior and informed consent.

 

Projects

Deer Horn Tellurium-Gold-Silver-Copper Project

Deer Horn is located on 51.33 square kilometers (km) in west-central British Columbia, 36 km south of the prolific Huckleberry copper-molybdenum mine and 135 km southwest of the community of Burns Lake. It is one of few significant tellurium discoveries outside Asia and includes a 2.4 km-long vein system of high-grade gold, silver and tellurium, as well as broader zones of bulk-tonnage gold, silver and tellurium mineralization. The company completed a positive Preliminary Economic Estimate and has begun permitting for a 10,000-tonne bulk sample program to advance the project toward mine feasibility. It is North America’s only silver-gold-tellurium property with an NI 43-101 compliant tellurium resource, and it hosts a number of other mineralized targets and zone containing critical metals such as copper, tungsten and zinc.

First Tellurium owns 50% of the property, with an option to acquire up to a 75% interest. The company has engaged Dias Geophysical of Saskatoon, Saskatchewan, to conduct induced polarization (IP) geophysics on the Deer Horn Project in summer 2023. The program is designed to help develop drill targets for a subsequent drilling program.

Klondike Gold-Tellurium Project

The Klondike property is located in Saguache County, Colorado, southwest of Buena Vista in the state’s historical mining district. The company reports it has engaged Burgex Mining Consultants of Sandy, Utah, to stake additional claims around the Klondike property. The claims have been filed with the Bureau of Land Management.

Klondike demonstrates exceptional tellurium grades. Tellurium, used in high-efficiency cadmium telluride (Cd-Te) solar panels, next-generation lithium-ion batteries and thermoelectric devices to change heat into energy, is an essential element for the world’s transition to green energy.

The Klondike property was a top tellurium prospect owned previously by First Solar Inc., one of the world’s largest solar panel producers. First Solar terminated its worldwide raw materials exploration program in 2012 and sold the property to Colorado Klondike LLC, which optioned the project to First Tellurium. Colorado Klondike, led by First Solar’s former Exploration Manager in North America, is managing the upcoming exploration program.

The Colorado Geological Survey (CGS), in partnership with the Colorado School of Mines, reported on First Solar’s exploration at Klondike in 2015, noting: “Surface sampling by First Solar, Inc. in 2006 found very high tellurium grades of up to 3.3% (33,000 ppm), along with locally high gold grades. Tellurium grades at Klondike were the highest encountered in the company’s nationwide exploration program.”

Market Outlook

First Tellurium in spring 2023 referenced recent forecasts by the International Energy Agency (IEA) pointing to rapid growth in solar photovoltaic (solar PV) deployment worldwide. According to the agency, solar PV installations will generate more power by 2027 than any other energy source, including coal, natural gas and hydro. To meet this demand, consumption of both silver and tellurium, key components of solar panels, is expected to surge in coming years.

Chen Lin, founder of Lin Asset Management, has written in his investment newsletter for clients that solar PV is now the largest industrial usage of silver. He said that in 2022 solar PV production used about 12% of total silver demand, or about 120 million ounces of silver. Lin expects this number to rise dramatically in the coming years, and that is likely to lead to silver supply deficits for decades to come.

Lin points out that solar power is now the cheapest source of energy in many parts of the world and that all forecasts point to dramatic expansion of solar PV in the coming two decades. Conservative estimates forecast 300 gigawatts of solar PV production by 2027, up from the current level of about 200 gigawatts.

Management Team

Tyrone Docherty is President, Director and CEO of First Tellurium Corp. He previously served as President and CEO of Quinto Mining Inc., taking over when it had a market cap of $4 million. With limited resources in a difficult market environment, he raised more than $30 million and advanced Quinto’s Quebec iron ore property to a viable project. Quinto later sold for $175 million, with Quinto management taking shares of the purchaser, Consolidated Thompson Iron Mines, amounting to approximately 20-21% of that company. Consolidated Thompson Iron Mines sold two years later for $4.9 billion, giving the former Quinto team an enterprise value of approximately $1 billion. From 2012 to 2018, Mr. Docherty was Director and Chairman of Mason Graphite Inc. He has worked in the financial and minerals markets for more than 30 years.

Tony Fogarassy, M.Sc. LL.M., is Chairman of First Tellurium Corp. He is a lawyer and a geologist. His extensive legal and technical expertise includes minerals, oil and gas, coal and renewable energy projects and environmental and aboriginal/indigenous law in North America, Africa and Asia. He graduated as gold medalist in geological sciences from the University of British Columbia and in law from the London School of Economics.

First Tellurium Corp. (OTCQB: FSTTF), closed Wednesday's trading session at $0.061505, off by 4.3468%, on 30,500 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.047785/$0.154.

Recent News

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has received a Notice of Patent Grant from the Korean Patent Office. The patent, which is effective through 2037, covers the use of the company's lead drug candidate, Reqorsa(R) Immunogene Therapy, in combination with anti-PD-1 and PD-L1 antibodies. According to the announcement, this newest patent expands on previously granted patents covering the use of REQORSA in combination with immune checkpoint inhibitors applicable to the company's Acclaim-2 and Acclaim-3 clinical trials. Previous patents have been granted by authorized entities in the United States, Japan, Mexico, Russia, Australia, Chile and China. "We continue to secure exclusivity for our drug combinations of REQORSA with PD-1 antibodies, such as Keytruda(R), and PD-L1 antibodies, such as Tecentriq(R), for the treatment of cancer in some of the largest markets," said Genprex senior vice president of intellectual property and licensing Thomas Gallagher in the press release. "It is important that we continue to add to our global intellectual property estate and to build protection around our drug combinations as we advance REQORSA through the clinic."

To view the full press release, visit https://ibn.fm/jxx3O

Genprex Inc. (GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Wednesday's trading session at $4.19, off by 0.475059%, on 53,365 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $3.8797/$46.00.

Recent News

Clene Inc. (NASDAQ: CLNN)

The QualityStocks Daily Newsletter would like to spotlight Clene Inc. (NASDAQ: CLNN).

Clene (NASDAQ: CLNN) (along with its subsidiaries, "Clene") and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, today announced its full year 2023 financial results. In addition, the company provided recent operating highlights for the clinical programs in amyotrophic lateral sclerosis ("ALS") and multiple sclerosis ("MS"). "In 2024 we will continue to advance our regulatory discussions with the U.S. Food and Drug Administration (‘FDA') that we anticipate will include new data on biomarkers, as well as additional clinical function and survival data in people living with ALS," said Rob Etherington, president and CEO of Clene. "Having held our initial discussion with the FDA in the fourth quarter of last year, we have a clear understanding of the additional data required to support an accelerated approval pathway filing for CNM-Au8(R). We believe that we can provide additional supportive evidence to advance discussions with the FDA with the potential to file an NDA later this year."

To view the full press release, visit https://ibn.fm/PV7FU

Clene Inc. (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple sclerosis (MS).

Its lead drug candidate is CNM-Au8®, an oral suspension developed to restore neuronal health and function by increasing energy production and utilization by driving critical cellular energy producing reactions that enable neuroprotection and remyelination to increase neuronal and glial resilience to disease-relevant stressors. CNM-Au8 is being studied in various clinical trials, including the Harvard/MGH Healey ALS Platform clinical trial for patients with ALS; RESCUE-ALS, a completed proof-of-concept clinical trial in patients with early symptomatic ALS; the REPAIR trials, completed target engagement clinical trials showing brain energy metabolite change with CNM-Au8; and a completed MS clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing MS. The company also has a nanotherapeutic platform of drug discovery.

CNM-Au8

CNM-Au8, Clene’s lead asset, is a highly concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals. Multiple pathogenic insults contribute to neuronal death. Mitochondrial dysfunction and NAD+ decline is a common final pathway in neurodegeneration, with NAD+ as a critical determinant of cell survival and function. CNM-Au8’s catalytic mechanisms target the energetic deficits, oxidative stress and accumulation of misfolded proteins that are common to many neurodegenerative diseases.

The unique catalytic mechanism of action of CNM-Au8 is hypothesized to act as a neuroprotective and remyelinating therapy in neurodegenerative disease states in order to: (1) drive, support and maintain beneficial metabolic and energetic cellular reactions within diseased, stressed and/or damaged cells, (2) directly catalyze the reduction of harmful, reactive oxygen species (“ROS”) and (3) promote protein homeostasis via activation of the heat shock factor-1 pathway, recognized to dampen the cytotoxicity caused by misfolded and denatured proteins, which are known to occur ubiquitously in neurodegenerative diseases.

CNM-Au8 is used in combination with other agents, has no known drug-drug interactions, and is designed to improve function and survival. The clinical effects of both function and survival were seen in its clinical ALS trials, as earlier announced.

More than 500 estimated years of collective exposure across ALS, MS, and Parkinson’s disease participants in CNM-Au8 clinical trials and Expanded Access Protocol (compassionate use) programs have been recorded without any observed safety signals.

CNM-Au8 is a federally registered trademark of Clene Inc. Clene, based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland, began in 2013.

Market Opportunity

ALS is the most prevalent adult-onset progressive motor neuron disease, affecting approximately 30,000 people in the U.S. and an estimated 500,000 people worldwide, with a life expectancy of typically three to five years. Clene estimates that global ALS treatment sales will be greater than $1 billion annually within the coming few years. Additional treatments affecting daily function and survival remain the market need.

Additionally, there are more than 2 million MS patients globally, and Clene estimates the market size to be worth more than $23 billion annually. While the MS community has been successful at limiting relapses, non-relapsing MS patients continue to clinically deteriorate even while receiving effective immunomodulatory disease-modifying therapies (“DMTs”). A critical unmet medical need remains for therapeutic interventions that protect neuronal function and myelin health independent of immunomodulation to address progression independent of relapse activity.

Management Team

Robert Etherington is President, Director and CEO of Clene. He has more than 30 years of sales, marketing and leadership experience in the pharmaceutical industry. Prior to joining Clene, he worked at Actelion Pharmaceuticals, the largest biopharma company in the European Union prior to its acquisition by Johnson & Johnson in 2017, where he led that company’s U.S. commercial operations. He began his pharmaceutical sales and marketing career at Parke-Davis, a division of Pfizer, where he rose to the position of Team Leader overseeing the drug Lipitor.

Mark Mortenson is Chief Science Officer at Clene. He is co-inventor of the technology platform developed to produce the company’s therapeutics. He is the inventor or co-inventor on 32 other U.S. patents and hundreds of corresponding international patents. He is a former chief patent counsel responsible for 5,500 U.S. and international patents and patent applications. He holds bachelor’s degrees in physics and ceramic engineering from Alfred University, a master’s degree in materials science from Penn State University and a J.D. from George Washington University.

Benjamin Greenberg, M.D., MHS, FAAN, is Head of Medical at Clene. He is an internationally recognized expert in disorders of the central nervous system. He is currently professor of neurology and Vice Chair of Clinical and Translational Research in the department of Neurology at University of Texas Southwestern Medical Center in Dallas. He holds a bachelor’s degree from Johns Hopkins, a master’s degree in molecular microbiology and immunology from the Johns Hopkins School of Public Health and graduated from Baylor College of Medicine. He served residency in neurology at The Johns Hopkins Hospital.

Morgan R. Brown is CFO at Clene. He has more than 30 years of finance and accounting experience, with 23 years at biotech, pharmaceutical and medical device companies. He has served in similar roles at Lipocine Inc., Innovus Pharmaceuticals, World Heart Corp., Lifetree Clinical Research and NPS Pharmaceuticals Inc. He previously worked at accounting firm KPMG. He is a CPA with a bachelor’s degree in accounting from Utah State University and an M.S. in business administration from the University of Utah.

Clene Inc. (NASDAQ: CLNN), closed Wednesday's trading session at $0.4396, off by 0.990991%, on 331,196 volume. The average volume for the last 3 months is 1.169M and the stock's 52-week low/high is $0.25/$1.42.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle ("EV") manufacturer, today provided an update on the U.S. Customs and Border Protection ("CBP") application for Class 1 EV cargo vans. According to the announcement, the CBP, on March 5, 2024, informed Rapid Response Defense Systems ("RRDS") counsel that a final determination on the ruling request needs to be issued by the U.S. General Services Administration ("GSA"). Based on CBP advice, Mullen and RRDS are proceeding with the GSA in order to finalize qualification of Mullen to sell Class 1 EV cargo vans to all branches of the U.S. government. "Mullen is well positioned to support the U.S. government's goal of transitioning its fleet to electric vehicles," said David Michery, CEO and chairman of Mullen Automotive.

To view the full press release, visit https://ibn.fm/hzgSn

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Wednesday's trading session at $6.4, off by 2.2901%, on 294,543 volume. The average volume for the last 3 months is 1.514M and the stock's 52-week low/high is $6.20/$3870.00.

Recent News

Electronic Servitor Publication Network Inc. (OTCQB: XESP)

The QualityStocks Daily Newsletter would like to spotlight Electronic Servitor Publication Network Inc. (OTCQB: XESP).

Electronic Servitor Publication Network Inc. (OTCQB: XESP) is a digital engagement company offering a managed service which provides digital activation and engagement solutions to companies that seek to optimize their growth. Its managed service is powered by a proven, proprietary technology – the Digital Engagement Engine™. This technology provides intelligent interaction management, dynamic content provisioning, and a logic-driven workflow, which creates digital experiences that accelerate an audience from awareness to action – driving growth.

Electronic Servitor Publication Network’s services are designed to drive growth for both established and developing organizations. Through the optimization of digital interactions within current and new communities, the Digital Engagement Engine™ ensures that client content is relevant, reaches the right audience, and connects with the intended person at the right time.

The company calls it ‘Growth as a Service’.

Client implementation is nearly effortless, since the solution is completely managed by the Electronic Servitor Publication Network team. This business model allows clients to focus on their brands, core product offerings, and content creation, while the company manages the technology and outcome.

The company is headquartered in Minneapolis, Minnesota.

Technology

Electronic Servitor Publication Network’s Digital Engagement Engine™ utilizes a combination of automation, unique data management, and a modern workflow built on a microservices architecture to achieve greater reach and lift. Using sophisticated data analysis and smart technology, the Digital Engagement Engine™ provides companies with the ability to maintain complete control of their content while creating meaningful relationships with new customers and revenue streams.

The Digital Engagement Engine™ isn’t just another marketing or technology tool; it’s a way to develop real connections with target markets.

Market Outlook

According to a report by ReportLinker.com, an award-winning market research firm, the global customer engagement solutions market was estimated at $19.3 billion in 2022 and is forecast to grow to $32.2 billion by 2027, achieving a CAGR of 10.8% during the forecast period.

The report notes that these engagement solutions are vital to companies seeking to widen their customer bases, reduce customer churn rates and increase customer retention. These perceived benefits of customer engagement solutions are likely to drive their growing adoption around the globe during the forecast period, according to the report.

Management Team

Peter Hager is President and CEO of Electronic Servitor. He joined the company from Pointward Inc., a medtech customer engagement agency that provided solutions to drive market entry, growth, and commercialization for Fortune 500 health care brands and medtech startups. He has founded and managed multiple technology, professional services and medtech organizations throughout his career. Mr. Hager holds a bachelor’s degree from Macalester College in St. Paul, Minnesota, with concentrations in economics and psychology.

Jim Kellogg is CFO of Electronic Servitor. He has served as the principal of J. Kellogg & Company Inc., a business and tax consultant, since 2005. He has provided legal support to clients’ business valuations, business interruption and divorce property valuations. He has worked as a professional tax adviser since 1983. Mr. Kellogg obtained his JD with emphasis on taxation from Western State University College of Law and was certified as a financial planner by the College for Financial Planning in 1990.

Thomas (Denny) Spruce, RPh, is COO of Electronic Servitor. He oversees company infrastructure, regulatory reporting, and strategic partner relationships, among other roles and responsibilities. He joined the company in March 2022 and, since that time, has implemented foundational support processes, developed contractual relationships with service providers, managed financial and regulatory reporting and overseen contract development and management with the legal team. Mr. Spruce obtained a BS in Pharmacy from the University of Arkansas.

Electronic Servitor Publication Network Inc. (XESP), closed Wednesday's trading session at $0.32, even for the day. The average volume for the last 3 months is 3,105 and the stock's 52-week low/high is $0.05/$0.55.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.